BMC Cancer unveils new plans to expand the scope of its Clinical Oncology section with the appointment of a new Section Editor and sub-section, as “Surgical oncology and imaging” joins forces with “Chemotherapy and radiation”
As Stephen Povoski and Nathan Hall discuss in their recent Editorial to mark the reworked scope of its Clinical oncology section, cancer requires a multidisciplinary approach to maximize the chance of successful treatment. BMC Cancer has always strived to consider articles addressing all aspects of cancer basic science and clinical research. However submissions in the areas of surgical oncology and cancer imaging have so far been underrepresented.
In order to engage these communities we have revamped our Clinical oncology section, which now has an expanded scope that includes clinical and basic science research that impacts on the treatment of cancer using not only chemotherapy and radiation, but also surgery and imaging. We are delighted to introduce Stephen Povoski as the Section Editor of the new sub-section entirely dedicated to surgical oncology and imaging. Like Steve we are confident the new sub-section will represent an important area of future growth for BMC Cancer and look forward to receiving your submissions.
For pre-submission enquiries to BMC Cancer, please contact the journal’s Executive Editor at Dafne.Solera@biomedcentral.com.
[posted on behalf of Dafne Solera]